Cryoport, Inc. CYRX
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- +98.44%
- 1 year
- +127.60%
5D +0.43 (+2.18%)
- Market cap
- 964.87M
- Revenue (ttm)
- 192.44M
- Profit margin
- -21.46%
- EPS (ttm)
- -0.90
- Shares out
- 50.65M
- Forward P/E
- -38.54
- YTD return
- +98.44%
- 1-year return
- +127.60%
- 50-day average
- 17.60
- 200-day average
- 13.81
- Volume
- 814.78K
- Avg volume
- 847.14K
- Open
- 19.17
- Previous close
- 19.55
- Day's range
- 18.83 – 19.45
- 52-week range
- 7.61 – 21.78
- Beta
- 1.87
- Analysts
- Strong Buy
- Price target
- 22.33 (+17.2%)
- Earnings date
- Mar 2, 2027
Key statistics
- Enterprise value
- 887.54M
- PEG ratio
- 62.13
- Price / sales
- 5.31
- Price / book
- 2.35
- Revenue growth
- 13.50%
- Free cash flow
- -10.91M
- Total cash
- 393.08M
- Total debt
- 231.51M
- Return on equity
- -7.44%
- Short % of float
- 8.26%
Fundamental scorecard
7 of 25 checks passed on CYRX’s reported financials
7of 25 checks passed
- Value 0 of 5
- Growth 3 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: strong buy
- Target (low)
- 18.00
- Target (mean)
- 22.33
- Target (high)
- 28.00
- Strong buy1
- Buy7
- Hold1
- Sell0
- Strong sell0
Next earnings
Mar 2, 2027
Expected Mar 2, 2027. Consensus EPS estimate -0.14667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 2, 2027 | Dec 30, 2026 | -0.18 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | -0.17685 | -0.25 | -0.07 | -41.36% |
| Aug 6, 2026 | Jun 30, 2026 | -0.19333 | -0.20 | -0.01 | -3.45% |
| May 4, 2026 | Mar 31, 2026 | -0.20 | -0.23 | -0.03 | -15.00% |
| Mar 3, 2026 | Dec 31, 2025 | -0.19 | -0.21 | -0.02 | -10.53% |
| Nov 4, 2025 | Sep 30, 2025 | -0.23 | -0.18 | +0.05 | +21.74% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Keybanc | main | Overweight | Overweight |
| Nov 6, 2026 | Needham | main | Buy | Buy |
| Oct 13, 2026 | BTIG | main | Buy | Buy |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 18, 2026 | BTIG | reit | Buy | Buy |
| Aug 7, 2026 | Guggenheim | main | Buy | Buy |
About Cryoport, Inc.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
- Sector
- Industrials
- Industry
- Integrated Freight & Logistics
- Country
- United States
- Website
- cryoportinc.com
News
12 Health Care Stocks Moving In Friday's Intraday Session Keybanc Maintains Overweight on CryoPort, Raises Price Target to $20
Needham Maintains Buy on CryoPort, Raises Price Target to $28
CryoPort Q3 2026 Earnings Call Transcript CryoPort Raises FY2026 Sales Guidance from $192.000M-$196.000M to $197.000M-$199.000M vs $195.441M Est
CryoPort Q3 EPS $(0.25) Misses $(0.18) Estimate, Sales $50.220M Beat $48.828M Estimate
Your note
Sign in to keep a note on CYRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BADDOUR LINDA | Director | Stock Award(Grant) | Jun 4, 2026 | 68,099 |
| HANCOCK DANIEL M | Director | Sale | Nov 8, 2026 | 69,052 |
| HARIRI ROBERT J | Director | Stock Award(Grant) | Jun 4, 2026 | 61,625 |
| MANDALAM RAMKUMAR | Director | Sale | Jun 7, 2026 | 67,894 |
| SAWICKI MARK W | Officer | Sale | Nov 9, 2026 | 92,356 |
| SHELTON JERRELL WILSON | Chief Executive Officer | Sale | Aug 10, 2026 | 1,201,810 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.80% | 3,954,275 | 79.76M | Sep 29, 2026 |
| Morgan Stanley | 5.05% | 2,558,686 | 51.61M | Sep 29, 2026 |
| Cadian Capital Management, LP | 4.77% | 2,418,947 | 48.79M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.24% | 2,147,343 | 43.31M | Sep 29, 2026 |
| Fred Alger Management, LLC | 3.33% | 1,690,723 | 34.10M | Sep 29, 2026 |
| Millennium Management Llc | 2.83% | 1,435,856 | 28.96M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,523,868 | 30.74M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.53% | 1,281,414 | 25.85M | Sep 29, 2026 |
| First Eagle Funds-First Eagle Small Cap Opportunity Fund | 2.25% | 1,141,648 | 23.03M | Jul 30, 2026 |
| ALGER FUNDS-Alger Small Cap Focus Fund | 2.11% | 1,068,554 | 21.55M | Jul 30, 2026 |
| CALAMOS INVESTMENT TRUST/IL-Calamos Timpani Small Cap Growth Fund | 1.47% | 742,856 | 14.98M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.14% | 578,058 | 11.66M | Jun 29, 2026 |
